HTL Biotechnology launches HTL8
A new production unit dedicated to pharmaceutical-grade Polynucleotides (DNA) at our Javené site.
HTL Biotechnology has 45 years of track record in Polynucleotides (PDRN-PN) production.
We are recognised for being able to provide Polynucleotides for both topical and injectable applications, with a very high level of purity.
Features
Advantages
Applications
Cosmetics
Improve skin quality
Regenerative medecine
Healing properties
Biostimulant properties